Launch of second "3 by 5" progress report

Davos, Switzerland
26 January 2005

Main message

Thanks to national and international commitment, we're really making progress towards the "3 by 5" target — getting more people onto treatment and linking treatment to care and prevention.

The world has reached the target for 2004

The target for December 2004 was 700 000. WHO/UNAIDS estimate that slightly more than 700 000 people were on treatment in developing countries by the end of the year. Prevention activities are rapidly expanding at the same time.

Countries are making it happen

In the last 6 months the number of people on treatment in sub-Saharan Africa and in Asia have doubled and in Latin America they have continued to improve. National determination is making it happen:

  • in sub-Saharan Africa: Botswana, Namibia and Uganda have achieved 25% coverage, and 12 other African countries have achieved 10%;
  • in Asia: Thailand leads the way with 900 sites and 3000 people a month starting treatment;
  • in South America: Brazil leads the way with 100% coverage, and 9 other countries with over 50% coverage.

Partnerships are the driving force in treatment scale-up

Partnerships have continued to increase: there are now 136 partnerships formally involved in pursuing the "3 by 5" target as advocates, donors, advisers and service providers.

New financial commitments make scale-up a reality

The Global Fund to Fight AIDS, Tuberculosis and Malaria; the US President's Emergency Plan for AIDS Relief; and the World Bank have played a major part in making scale-up possible.

Treatment works

Adherence to ARV therapy is 90% and above in some projects. Survival rates on treatment are very encouraging. Some of these figures equal or surpass those for treatment success in rich countries.

There are real challenges to reaching "3 by 5"

To reach the other 2.3 million people by the end of this year, an extraordinary effort is needed by all countries and all partners:

  • the three countries which need to do most with most unmet need are South Africa, India, and Nigeria;
  • the main obstacles are the continued high cost of treatment, the uneven distribution of services, and the continued shortage of human resources.

More funds are urgently needed

A further $ 2 billion is needed. In-country drug prices need to continue to fall. Service delivery systems need to become more efficient. Countries need to make bold financial commitments and speed up funding distribution.


Against the expectations of many, national leaders and the global community have started a major change in the world. The challenge now is to see it through.